Duexis generic
Duexis, an oral tablet drug owned by Horizon, contains two active ingredients: Famotidine and Ibuprofen. This drug was first introduced to the market on 23rd April 2011.
When will Duexis generic be available?
The generic version of Duexis is expected to be available after 18th July 2026. This is because the last drug patent held by Duexis is set to expire on that date.
Duexis uses
Duexis is commonly used to provide relief from the signs and symptoms of rheumatoid arthritis and osteoarthritis. Furthermore, it decreases the risk of developing upper gastrointestinal ulcers in patients who are required to take ibuprofen for their medical conditions.
Duexis patent expiration
Duexis holds a total of 5 drug patents, with no expired patents to date. The last patent is slated to expire on 18th July 2026, which will make way for the release of Duexis generic. Below are the details of the patent: